Towards a revised nomenclature for P1 and P2 receptors.
作者信息
Fredholm B B, Abbracchio M P, Burnstock G, Dubyak G R, Harden T K, Jacobson K A, Schwabe U, Williams M
机构信息
Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
出版信息
Trends Pharmacol Sci. 1997 Mar;18(3):79-82. doi: 10.1016/s0165-6147(96)01038-3.
Abstract
摘要
相似文献
1
Towards a revised nomenclature for P1 and P2 receptors.
Trends Pharmacol Sci. 1997 Mar;18(3):79-82. doi: 10.1016/s0165-6147(96)01038-3.
2
Nomenclature and classification of purinoceptors.
Pharmacol Rev. 1994 Jun;46(2):143-56.
3
Receptors for adenine nucleotides and nucleosides: subclassification, distribution, and molecular characterization.
Pharmacol Rev. 1994 Dec;46(4):449-66.
4
Purinergic receptors.
Pol J Pharmacol. 1996 Sep-Oct;48(5):457-65.
5
The past, present and future of purine nucleotides as signalling molecules.
Neuropharmacology. 1997 Sep;36(9):1127-39. doi: 10.1016/s0028-3908(97)00125-1.
6
Purinoceptors in the nervous system.
Pharmacol Toxicol. 1995 Apr;76(4):228-39. doi: 10.1111/j.1600-0773.1995.tb00135.x.
7
Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures.
Neurosci Lett. 1998 Feb 20;242(3):159-62. doi: 10.1016/s0304-3940(98)00067-6.
8
International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits.
Pharmacol Rev. 2001 Mar;53(1):107-18.
9
International Union of Basic and Clinical Pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update.
Pharmacol Rev. 2011 Mar;63(1):1-34. doi: 10.1124/pr.110.003285. Epub 2011 Feb 8.
10
Purinoceptors: are there families of P2X and P2Y purinoceptors?
Pharmacol Ther. 1994;64(3):445-75. doi: 10.1016/0163-7258(94)00048-4.
引用本文的文献
1
Purinergic System Transcript Changes in the Dorsolateral Prefrontal Cortex in Suicide and Major Depressive Disorder.
Int J Mol Sci. 2025 Feb 20;26(5):1826. doi: 10.3390/ijms26051826.
2
Ectonucleotidase inhibitors: targeting signaling pathways for therapeutic advancement-an in-depth review.
Purinergic Signal. 2025 Apr;21(2):221-265. doi: 10.1007/s11302-024-10031-0. Epub 2024 Jul 3.
3
Probing Adenosine and P2 Receptors: Design of Novel Purines and Nonpurines as Selective Ligands.
Drug Dev Res. 2001 Jan-Feb;52(1-2):178-186. doi: 10.1002/ddr.1113.
4
Two Distinct P2Y Receptors Are Involved in Purine- and Pyrimidine-Evoked Ca Elevation in Mammalian Brain Astrocytic Cultures.
Drug Dev Res. 2001 Jan-Feb;52(1-2):122-132. doi: 10.1002/ddr.1106.
5
Astrocyte-targeted siRNA delivery by adenosine-functionalized LNP in mouse TBI model.
Mol Ther Nucleic Acids. 2023 Oct 20;34:102065. doi: 10.1016/j.omtn.2023.102065. eCollection 2023 Dec 12.
6
A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression.
Int J Mol Sci. 2023 Feb 23;24(5):4428. doi: 10.3390/ijms24054428.
7
Individuals with bipolar disorder have a higher level of uric acid than major depressive disorder: a case-control study.
Sci Rep. 2021 Sep 15;11(1):18307. doi: 10.1038/s41598-021-97955-4.
8
Pathways and Mechanism of Caffeine Binding to Human Adenosine A Receptor.
Front Mol Biosci. 2021 Apr 27;8:673170. doi: 10.3389/fmolb.2021.673170. eCollection 2021.
9
Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases.
Cells. 2020 Mar 24;9(3):785. doi: 10.3390/cells9030785.
10
Purinergic system in psychiatric diseases.
Mol Psychiatry. 2018 Jan;23(1):94-106. doi: 10.1038/mp.2017.188. Epub 2017 Sep 26.
本文引用的文献
1
Early expression of a novel nucleotide receptor in the neural plate of Xenopus embryos.
J Biol Chem. 1997 May 9;272(19):12583-90. doi: 10.1074/jbc.272.19.12583.
2
Receptors responsive to extracellular pyrimidine nucleotides.
Trends Pharmacol Sci. 1997 Mar;18(3):83-6. doi: 10.1016/s0165-6147(96)01035-8.
3
Release, metabolism and interconversion of adenine and uridine nucleotides: implications for G protein-coupled P2 receptor agonist selectivity.
Trends Pharmacol Sci. 1997 Feb;18(2):43-6.
4
The selective adenosine A2A receptor antagonist SCH 58261 discriminates between two different binding sites for [3H]-CGS 21680 in the rat brain.
Naunyn Schmiedebergs Arch Pharmacol. 1996 Oct;354(4):539-41. doi: 10.1007/BF00168448.
5
Characterization and chromosomal localization of a human P2X receptor from the urinary bladder.
Recept Channels. 1995;3(4):283-9.
6
Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels.
J Neurosci. 1996 Apr 15;16(8):2495-507. doi: 10.1523/JNEUROSCI.16-08-02495.1996.
7
Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor.
Br J Pharmacol. 1996 May;118(1):167-73. doi: 10.1111/j.1476-5381.1996.tb15381.x.
8
Molecular cloning of a novel P2 purinoceptor from human erythroleukemia cells.
J Biol Chem. 1996 Aug 2;271(31):18363-7. doi: 10.1074/jbc.271.31.18363.
9
A novel G protein-coupled P2 purinoceptor (P2Y3) activated preferentially by nucleoside diphosphates.
Mol Pharmacol. 1996 Aug;50(2):258-65.
10
Evidence for high-affinity binding sites for the adenosine A2A receptor agonist [3H] CGS 21680 in the rat hippocampus and cerebral cortex that are different from striatal A2A receptors.
Naunyn Schmiedebergs Arch Pharmacol. 1996 Feb;353(3):261-71. doi: 10.1007/BF00168627.
Zotero 插件